Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
HK Stock MarketDetailed Quotes
GRAND PHARMA (00512)
- 7.810
- -0.100-1.26%
Market Closed Jan 16 16:08 CST
27.72BMarket Cap13.33P/E (TTM)
7.960High7.780Low3.19MVolume7.910Open7.910Prev Close24.96MTurnover0.09%Turnover Ratio11.24P/E (Static)3.55BShares10.20052wk High1.62P/B27.72BFloat Cap3.78052wk Low0.26Dividend TTM3.55BShs Float10.200Historical High0.260Dividend LFY2.28%Range %0.102Historical Low7.831Avg Price500Lot Size3.33%Div Yield TTM3.33%Div Yield LFY
GRAND PHARMA (00512) Cash Flow
All
YOY
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 21.68%2.85B | ---- | -6.86%2.34B | ---- | -9.65%2.52B | ---- | 34.35%2.79B | ---- | 52.92%2.07B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 18.53%-6.31M | ---- | 60.90%-7.75M | ---- | -105.61%-19.81M | ---- | 46.62%-9.63M | ---- | -61.82%-18.05M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.87%-1.17M | ---- | -485.71%-6.44M |
| Attributable subsidiary (profit) loss | ---- | -694.69%-148.72M | ---- | -42.89%25.01M | ---- | 138.46%43.79M | ---- | -83.71%-113.86M | ---- | 46.09%-61.98M |
| Impairment and provisions: | ---- | 0.59%173.24M | ---- | 821.46%172.22M | ---- | 1,239.78%18.69M | ---- | -94.63%1.4M | ---- | -59.86%25.97M |
| -Impairmen of inventory (reversal) | ---- | 243.93%50.79M | ---- | 180.49%14.77M | ---- | 405.28%5.27M | ---- | -87.24%1.04M | ---- | 18.82%8.17M |
| -Impairment of trade receivables (reversal) | ---- | 26.49%72.98M | ---- | 354.83%57.7M | ---- | -292.31%-22.64M | ---- | 66.06%11.77M | ---- | 92.66%7.09M |
| -Impairment of goodwill | ---- | 25.39%49.07M | ---- | 7.39%39.14M | ---- | --36.44M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -99.35%395K | ---- | 16,264.80%60.62M | ---- | 96.72%-375K | ---- | -206.59%-11.42M | ---- | -80.21%10.72M |
| Revaluation surplus: | ---- | -453.08%-680.31M | ---- | -2,093.92%-123.01M | ---- | 101.22%6.17M | ---- | -62.55%-504.91M | ---- | -6,720.20%-310.62M |
| -Fair value of investment properties (increase) | ---- | 19.60%-4.39M | ---- | 74.46%-5.45M | ---- | 27.81%-21.35M | ---- | 35.21%-29.58M | ---- | -554.55%-45.65M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | 178.98%31.37M | ---- | -575.69%-39.72M | ---- | --8.35M | ---- | ---- |
| -Other fair value changes | ---- | -353.88%-675.93M | ---- | -321.48%-148.92M | ---- | 113.90%67.24M | ---- | -82.54%-483.68M | ---- | -2,371.32%-264.97M |
| Asset sale loss (gain): | ---- | -92.37%997K | ---- | -56.25%13.06M | ---- | 661.71%29.86M | ---- | 9.28%3.92M | ---- | -88.64%3.59M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -92.37%997K | ---- | 427.63%13.06M | ---- | -36.84%2.48M | ---- | 9.28%3.92M | ---- | -88.64%3.59M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | --27.38M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 28.44%503.75M | ---- | -0.68%392.21M | ---- | 16.32%394.91M | ---- | 18.27%339.52M | ---- | -39.84%287.06M |
| -Depreciation | ---- | 11.15%359.32M | ---- | -1.66%323.27M | ---- | 7.60%328.71M | ---- | 17.58%305.5M | ---- | -43.17%259.82M |
| -Amortization of intangible assets | ---- | 223.38%94.06M | ---- | -10.06%29.09M | ---- | 89.97%32.34M | ---- | 46.00%17.02M | ---- | 40.40%11.66M |
| Financial expense | ---- | -12.14%180.24M | ---- | 49.20%205.15M | ---- | 47.90%137.49M | ---- | -19.46%92.96M | ---- | -21.22%115.42M |
| Special items | ---- | -3,839.95%-76.44M | ---- | 95.50%-1.94M | ---- | -246.94%-43.15M | ---- | 92.47%-12.44M | ---- | -1.31%-165.07M |
| Operating profit before the change of operating capital | ---- | -7.30%2.8B | ---- | -2.13%3.02B | ---- | 19.49%3.08B | ---- | 32.84%2.58B | ---- | 8.50%1.94B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 174.98%74.54M | ---- | 66.33%-99.41M | ---- | -148.69%-295.28M | ---- | -17.60%-118.74M | ---- | -55.04%-100.96M |
| Accounts receivable (increase)decrease | ---- | -128.82%-453.62M | ---- | 63.07%-198.24M | ---- | 19.59%-536.77M | ---- | -488.35%-667.54M | ---- | 39.34%-113.46M |
| Accounts payable increase (decrease) | ---- | -162.16%-177.24M | ---- | 232.11%285.13M | ---- | -139.12%-215.83M | ---- | 2,220.43%551.73M | ---- | 108.68%23.78M |
| Special items for working capital changes | ---- | 222.76%135.85M | ---- | -171.41%-110.66M | ---- | 341.80%154.96M | ---- | -73.37%-64.09M | ---- | -120.93%-36.96M |
| Cash from business operations | ---- | -17.87%2.38B | ---- | 32.12%2.9B | ---- | -3.99%2.19B | ---- | 33.05%2.28B | ---- | 19.02%1.72B |
| Other taxs | ---- | -1.94%-480.24M | ---- | -34.88%-471.08M | ---- | -25.94%-349.26M | ---- | -6.70%-277.32M | ---- | -88.75%-259.91M |
| Special items of business | -66.49%76.05M | ---- | -69.70%226.99M | ---- | -4.93%749.14M | ---- | -19.45%787.96M | ---- | 122.93%978.23M | ---- |
| Net cash from operations | -66.49%76.05M | -21.72%1.9B | -69.70%226.99M | 31.60%2.42B | -4.93%749.14M | -8.13%1.84B | -19.45%787.96M | 37.76%2.01B | 122.93%978.23M | 11.66%1.46B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -18.53%6.31M | ---- | -60.90%7.75M | ---- | 105.61%19.81M | ---- | -46.62%9.63M | ---- | 61.82%18.05M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | -3.35%192.1M | ---- | -51.64%198.75M | ---- | --410.97M |
| Loan receivable (increase) decrease | ---- | 131.04%14.95M | ---- | -409.33%-48.18M | ---- | -88.08%15.58M | ---- | 133.05%130.64M | ---- | -236.05%-395.3M |
| Decrease in deposits (increase) | ---- | 1,911.49%32.63M | ---- | -130.71%-1.8M | ---- | -75.46%5.86M | ---- | -74.17%23.9M | ---- | 286.01%92.52M |
| Sale of fixed assets | ---- | -85.31%971K | ---- | 232.61%6.61M | ---- | -91.65%1.99M | ---- | 1,453.82%23.79M | ---- | --1.53M |
| Purchase of fixed assets | -2.96%-198.11M | -13.95%-555.78M | 15.53%-192.41M | 22.12%-487.73M | -163.65%-227.78M | -32.79%-626.22M | 68.66%-86.39M | -125.62%-471.57M | -237.10%-275.66M | 63.07%-209.01M |
| Purchase of intangible assets | -24,501.46%-50.68M | -563.52%-66.1M | 72.86%-206K | 97.83%-9.96M | 99.52%-759K | -608.15%-458.86M | -304.48%-156.95M | 6.89%-64.8M | ---38.8M | -108.71%-69.59M |
| Acquisition of subsidiaries | 55.35%-321.59M | -568.06%-1.18B | -390.46%-720.29M | 34.47%-176.42M | ---146.86M | -9.70%-269.22M | ---- | ---245.41M | ---125.58M | ---- |
| Recovery of cash from investments | --690.54M | -98.71%21.17M | ---- | 20.94%1.64B | ---- | 1,014.89%1.35B | ---- | 981.09%121.48M | ---- | -1.53%11.24M |
| Cash on investment | -369.47%-45.08M | 81.10%-272.88M | 108.08%16.73M | 44.37%-1.44B | 73.03%-207M | -73.43%-2.6B | -219.27%-767.47M | -8.45%-1.5B | 70.37%-240.39M | -1,467.20%-1.38B |
| Other items in the investment business | -32.75%16.66M | ---- | 260.89%24.76M | ---- | -75.58%6.86M | ---- | -61.52%28.1M | -81.87%1.17M | -26.82%73.01M | 485.71%6.44M |
| Net cash from investment operations | 110.53%91.73M | -287.27%-2B | -51.41%-871.42M | 78.15%-515.75M | 41.43%-575.54M | -33.42%-2.36B | -61.79%-982.72M | -16.91%-1.77B | 23.44%-607.41M | -241.13%-1.51B |
| Net cash before financing | 126.04%167.79M | -105.20%-99.25M | -471.20%-644.43M | 468.97%1.91B | 189.14%173.61M | -318.61%-517.43M | -152.52%-194.76M | 513.68%236.7M | 204.58%370.82M | -106.65%-57.22M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -19.63%2.31B | 89.08%4.48B | 169.02%2.87B | -23.96%2.37B | 39.17%1.07B | 57.32%3.12B | -52.96%767.23M | -7.51%1.98B | 15.08%1.63B | 31.28%2.14B |
| Refund | -34.05%-2.22B | 3.39%-3.31B | -63.88%-1.66B | -55.70%-3.42B | -27.89%-1.01B | -36.12%-2.2B | 32.10%-791.83M | 15.04%-1.62B | -69.20%-1.17B | -7.81%-1.9B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 887.81%1.01B |
| Interest paid - financing | 12.96%-74.97M | 11.80%-180.24M | 23.93%-86.14M | -48.63%-204.36M | -79.13%-113.23M | -47.90%-137.49M | -167.05%-63.21M | 19.46%-92.96M | ---23.67M | 10.25%-115.42M |
| Dividends paid - financing | 1.35%-910.47M | -78.54%-933.18M | -85.71%-922.89M | -31.32%-522.67M | -27.27%-496.94M | 0.42%-398.01M | 0.35%-390.45M | -21.30%-399.68M | ---391.83M | -11.37%-329.49M |
| Absorb investment income | ---- | --4.69M | ---- | ---- | ---- | ---- | ---- | --17.89M | ---- | ---- |
| Other items of the financing business | 24.81%-14.97M | ---- | 81.14%-19.91M | -84.18%-81.01M | -107.50%-105.56M | 79.82%-43.99M | -989.99%-50.87M | -2,058.19%-218.02M | 128.69%5.72M | 87.92%-10.1M |
| Net cash from financing operations | -598.19%-916.64M | 101.59%29.96M | 127.85%183.99M | -677.80%-1.89B | -24.85%-660.64M | 198.15%327M | -1,060.77%-529.14M | -143.03%-333.17M | -92.22%55.07M | 209.02%774.27M |
| Effect of rate | 21.93%-113.03M | 156.88%70.56M | 45.03%-144.77M | -4.76%-124.06M | -4,547.32%-263.37M | -1,036.84%-118.42M | -92.10%5.92M | -79.06%12.64M | 545.48%74.93M | 2,022.13%60.37M |
| Net Cash | -62.64%-748.85M | -450.84%-69.29M | 5.46%-460.43M | 110.37%19.75M | 32.72%-487.03M | -97.39%-190.43M | -269.97%-723.9M | -113.45%-96.48M | 20.44%425.89M | 377.51%717.05M |
| Begining period cash | 0.09%1.34B | -7.22%1.34B | -7.22%1.34B | -17.62%1.44B | -17.62%1.44B | -4.56%1.75B | -4.56%1.75B | 73.39%1.84B | 73.39%1.84B | 16.12%1.06B |
| Cash at the end | -34.77%479.1M | 0.09%1.34B | 5.90%734.5M | -7.22%1.34B | -32.98%693.61M | -17.62%1.44B | -55.73%1.03B | -4.56%1.75B | 67.44%2.34B | 73.39%1.84B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
New Consumption Stocks New Consumption Stocks
New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations. New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations.
View More
Hot Topics Hot Topics
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde
年頭旺到年尾
Aug 21, 2025 06:11
Are you foolish? What's the point of knowing your mistakes?
牛牛課堂
Sep 12, 2025 17:29
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?